| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Common Stock | Options Exercise | $61,771 | +1,255 | +33% | $49.22 | 5,024 | 28 Oct 2024 | Direct | |
| transaction | TMP | Common Stock | Tax liability | $67,007 | -1,103 | -22% | $60.75 | 3,921 | 28 Oct 2024 | Direct | F1 |
| holding | TMP | Common Stock | 1,277 | 28 Oct 2024 | by 401(k) | ||||||
| holding | TMP | Common Stock | 2,527 | 28 Oct 2024 | by ESOP |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Stock Appreciation Rights (SAR) | Options Exercise | $0 | -1,255 | -100% | $0.000000 | 0 | 28 Oct 2024 | Common Stock | 1,255 | $49.22 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Shares withheld for Option cost and taxes. |
| F2 | Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant. |